A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization

Cell - United States
doi 10.1016/j.cell.2018.09.035
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy